Friob MC et al. |
A combined HPLC-ELISA evaluation of FK 506 in transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721265
|
Machida M et al. |
Effect of temperature and hematocrit on plasma concentration of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721266
|
Kawauchi M et al. |
Plasma level of FK 506 in newborn goats and infant baboons. |
1991 |
Transplant. Proc. |
pmid:1721267
|
Iwasaki K et al. |
Pharmacokinetic study of FK 506 in the rat. |
1991 |
Transplant. Proc. |
pmid:1721268
|
O'Neill EA et al. |
The FK 506-sensitive nature of the interleukin-2 promoter is derived from a specific array of multiple regulatory elements. |
1991 |
Transplant. Proc. |
pmid:1721298
|
Nelson PA et al. |
Effect of immunosuppressive drugs on cytokine gene transcription studied by message amplification phenotyping (MAPPing) polymerase chain reaction. |
1991 |
Transplant. Proc. |
pmid:1721299
|
Dumont FJ et al. |
Up-regulation of gene expression by FK 506. |
1991 |
Transplant. Proc. |
pmid:1721300
|
Rao P et al. |
Effect of FK 506 on FK-binding protein and transforming growth factor beta gene expression. |
1991 |
Transplant. Proc. |
pmid:1721301
|
Takai K et al. |
Immunosuppressive effects of FK 506 on rat lymphoid organs. |
1991 |
Transplant. Proc. |
pmid:1721329
|
Ishibashi M et al. |
Effect of FK 506 on generation of activated macrophages invading rejected skin allografts in rats: discrepancy of in vitro versus in vivo effects. |
1991 |
Transplant. Proc. |
pmid:1721330
|
Kawauchi M et al. |
Flow cytometric analysis of lymphocyte populations in FK 506-treated newborn goats. |
1991 |
Transplant. Proc. |
pmid:1721331
|
Borg AJ and Kumagai M |
FK 506 and xenogeneic human anti-porcine cellular reactivity. |
1991 |
Transplant. Proc. |
pmid:1721332
|
McCauley J et al. |
Renal transplantation under FK 506 in patients with previous loss of renal function due to hemolytic uremic syndrome. |
1991 |
Transplant. Proc. |
pmid:1721362
|
Zeevi A et al. |
Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection. |
1991 |
Transplant. Proc. |
pmid:1703341
|
|
Japanese study of FK 506 on kidney transplantation: results of an early phase II study. Japanese FK 506 Study Group. |
1991 |
Transplant. Proc. |
pmid:1721363
|
van Hoek B et al. |
Recurrence of ductopenic rejection in liver allografts after retransplantation for vanishing bile duct syndrome. |
1991 |
Transplant. Proc. |
pmid:1703343
|
Jensen CW et al. |
Pediatric renal transplantation under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721364
|
McCauley J et al. |
The question of FK 506 nephrotoxicity after liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1703344
|
Jordan ML et al. |
FK 506 conversion of renal allografts failing cyclosporine immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721365
|
Alessiani M et al. |
Infections in adult liver transplant patients under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1703345
|
Carroll PB et al. |
Synexin: a target protein for toxic effects of cyclosporine and FK 506 in endocrine cells. |
1991 |
Transplant. Proc. |
pmid:1721394
|
Scantlebury V et al. |
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. |
1991 |
Transplant. Proc. |
pmid:1721395
|
Carroll PB et al. |
FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication. |
1991 |
Transplant. Proc. |
pmid:1721396
|
Freise CE et al. |
Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. |
1991 |
Transplant. Proc. |
pmid:1721397
|
Eidelman BH et al. |
Neurologic complications of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721398
|
Steinmann B et al. |
Mechanism of action of FK 506 and cyclosporin. |
1991 |
Lancet |
pmid:1704088
|
Sewing KF and Christians U |
FK 506. |
1991 |
Lancet |
pmid:1704090
|
Murase N et al. |
Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation. |
1991 |
Transplant. Proc. |
pmid:1721424
|
Langrehr JM et al. |
Indefinite small bowel allograft survival after limited immunosuppressive therapy is not due to specific hyporesponsiveness. |
1991 |
Transplant. Proc. |
pmid:1721425
|
Takeda Y et al. |
Effect of FK 506 on the survival of rat small bowel allografts. |
1991 |
Transplant. Proc. |
pmid:1721426
|
Fukuzawa M et al. |
Effect of donor-specific transfusion and FK 506 on small intestine allotransplantation. |
1991 |
Transplant. Proc. |
pmid:1721427
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Neuberger J |
FK 506--a promise of good things to come? |
1991 |
Hepatology |
pmid:1711005
|
Halloran PF and Madrenas J |
The mechanism of action of cyclosporine: a perspective for the 90's. |
1991 |
Clin. Biochem. |
pmid:1711939
|
Palaszynski EW et al. |
Purification and characterization of cyclosporine and FK-506 binding proteins from a human T-helper cell line. |
1991 |
Clin. Biochem. |
pmid:1711940
|
Roat MI et al. |
Treatment of Cogan's syndrome with FK 506: a case report. |
1991 |
Transplant. Proc. |
pmid:1721457
|
Carroll PB et al. |
The use of FK 506 in new-onset type I diabetes in man. |
1991 |
Transplant. Proc. |
pmid:1721458
|
McCauley J et al. |
FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome. |
1991 |
Transplant. Proc. |
pmid:1721459
|
Carrieri G et al. |
Effect of FK 506 in the prophylaxis of autoimmune glomerulonephritis in NZB/WF1 mice. |
1991 |
Transplant. Proc. |
pmid:1721460
|
Brizuela L et al. |
Antifungal properties of the immunosuppressant FK-506: identification of an FK-506-responsive yeast gene distinct from FKB1. |
1991 |
Mol. Cell. Biol. |
pmid:1715022
|
Heitman J et al. |
Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. |
1991 |
Science |
pmid:1715094
|
Morris RE |
Rapamycin: FK506's fraternal twin or distant cousin? |
1991 |
Immunol. Today |
pmid:1715165
|
Baumann G et al. |
Cyclosporin A and FK-506 both affect DNA binding of regulatory nuclear proteins to the human interleukin-2 promoter. |
1991 |
New Biol. |
pmid:1715185
|
Katayama Y et al. |
Immunosuppressive effects of FK 506 and 15-deoxyspergualin in rat lung transplantation. |
1991 |
Transplant. Proc. |
pmid:1703690
|
Thomson AW |
The immunosuppressive macrolides FK-506 and rapamycin. |
1991 |
Immunol. Lett. |
pmid:1717376
|
Takaya S et al. |
Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. |
1991 |
Transplant. Proc. |
pmid:1703691
|
Steeves M et al. |
In-vitro interaction of a novel immunosuppressant, FK 506, and antacids. |
1991 |
J. Pharm. Pharmacol. |
pmid:1717676
|
Hildebrandt A et al. |
FK 506: short- and long-term treatment after cardiac transplantation in nonhuman primates. |
1991 |
Transplant. Proc. |
pmid:1703694
|
|
Unmasking immunosuppression. |
1991 |
Lancet |
pmid:1717800
|
Ericzon BG et al. |
Effect of FK 506 on glucose metabolism in the cynomolgus monkey: studies in pancreatic transplant recipients and nontransplanted animals. |
1991 |
Transplant. Proc. |
pmid:1703695
|